Challenges of immunosuppressive and antitrypanosomal drug therapy after heart transplantation in patients with chronic Chagas disease: A systematic review of clinical recommendations
Although contraindicated for decades, heart transplantation (HT) has finally become a feasible therapeutic option for the treatment of Chagasic patients with end-stage heart failure. Part of the success in achieving acceptable survival rates after HT is due to the enhancement of the pharmacological management of allograft rejection and reactivation of Trypanosoma cruzi infection.
Source: Transplantation Reviews - Category: Transplant Surgery Authors: Silas Santana Nogueira, Amanda Aparecida Felizardo, Ivo Santana Caldas, Reggiani Vilela Gon çalves, Rômulo Dias Novaes Tags: Review article Source Type: research
More News: Bone Graft | Cardiology | Chagas Disease | Heart | Heart Failure | Heart Transplant | Transplants